ArticlePharmaceuticals (Basel, Switzerland)2022

The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study.

Gabriella di Mauro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.